SLF CIL36590
Alternative Names: SLF-CIL36590Latest Information Update: 12 Sep 2023
At a glance
- Originator Chiesi Farmaceutici
- Class Antibronchitics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Chronic obstructive pulmonary disease in Italy, United Kingdom (Inhalation)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in Italy (Inhalation)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Chronic-obstructive-pulmonary-disease in United Kingdom (Inhalation)